Skip to NavigationSkip to content

Pharmafile - Research and Development News

The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). The...
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza.
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for HIV drugs,...
“In the life sciences industry, we see a shift toward transparency and collaboration,” says Robert Groebel, Vice President of Medical Strategy at...
A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all mothers following...
The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical...
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
Bristol-Myers Squibb’s Opdivo failed its primary endpoint in a Phase 3 trial investigating its efficacy in the treatment of newly diagnosed O6-...
Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of developing necrotizing fasciitis...
Pfizer’s Lorviqua (lorlatinib), or Lorbrena as it is known in the US, Canada and Japan, has just been awarded conditional marketing approval from...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches